id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2999113,d2c21b73-b3f1-415a-bdc2-e63cf8a56fbb,Q2,STONINGTON GLOBAL,401105189,"SORRENTO THERAPEUTICS, INC.",2023,second_quarter,PHA,Promoting non-opioid pain management alternatives.,"Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,,0,0,2023-07-05T19:16:07-04:00
2999114,d2c21b73-b3f1-415a-bdc2-e63cf8a56fbb,Q2,STONINGTON GLOBAL,401105189,"SORRENTO THERAPEUTICS, INC.",2023,second_quarter,CSP,Promoting non-opioid pain management alternatives.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2023-07-05T19:16:07-04:00